WELLS FARGO & COMPANY/MN - IMMIX BIOPHARMA INC ownership

IMMIX BIOPHARMA INC's ticker is and the CUSIP is 45258H106. A total of 32 filers reported holding IMMIX BIOPHARMA INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of IMMIX BIOPHARMA INC
ValueSharesWeighting
Q2 2024$653
-51.0%
330
-24.0%
0.00%
Q1 2024$1,332
-50.8%
434
+11.0%
0.00%
Q4 2023$2,706
+1287.7%
391
+586.0%
0.00%
Q3 2023$195
+72.6%
57
+35.7%
0.00%
Q2 2023$113
+63.8%
42
+10.5%
0.00%
Q1 2023$69
-18.8%
38
+2.7%
0.00%
Q4 2022$8537
+2.8%
0.00%
Q3 2022$036
-48.6%
0.00%
Q2 2022$070
+169.2%
0.00%
Q1 2022$0260.00%
Other shareholders
IMMIX BIOPHARMA INC shareholders Q2 2024
NameSharesValueWeighting ↓
Cable Car Capital LLC 796,100$1,576,2781.66%
AIGH Capital Management LLC 1,406,680$2,785,2260.87%
Bleichroeder LP 850,000$1,683,0000.50%
FNY Investment Advisers, LLC 32,500$640.04%
Invst, LLC 27,000$57,2400.01%
Corsair Capital Management 14,217$28,1500.01%
TRITONPOINT WEALTH, LLC 24,526$48,5610.01%
XTX Topco Ltd 17,663$34,9730.00%
Private Advisor Group, LLC 65,175$129,0470.00%
TOCQUEVILLE ASSET MANAGEMENT L.P. 37,800$74,8440.00%
View complete list of IMMIX BIOPHARMA INC shareholders